Order Article Reprints

Palacios Y, Ruiz A, Ramón-Luing LA, Ocaña-Guzman R, Barreto-Rodriguez O, Sánchez-Monciváis A, Tecuatzi-Cadena B, Regalado-García AG, Pineda-Gudiño RD, García-Martínez A, et al. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality. International Journal of Molecular Sciences. 2021; 22(16):8423. https://doi.org/10.3390/ijms22168423

Palacios, Yadira, Andy Ruiz, Lucero A. Ramón-Luing, Ranferi Ocaña-Guzman, Omar Barreto-Rodriguez, Anahí Sánchez-Monciváis, Brenda Tecuatzi-Cadena, Ana G. Regalado-García, Rey David Pineda-Gudiño, Alicia García-Martínez, and et al. 2021. "Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality" International Journal of Molecular Sciences 22, no. 16: 8423. https://doi.org/10.3390/ijms22168423

Palacios, Y., Ruiz, A., Ramón-Luing, L. A., Ocaña-Guzman, R., Barreto-Rodriguez, O., Sánchez-Monciváis, A., Tecuatzi-Cadena, B., Regalado-García, A. G., Pineda-Gudiño, R. D., García-Martínez, A., Juárez-Hernández, F., Farias-Contreras, J. P., Fricke-Galindo, I., Pérez-Rubio, G., Falfán-Valencia, R., Buendia-Roldan, I., Medina-Quero, K., & Chavez-Galan, L. (2021). Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality. International Journal of Molecular Sciences, 22(16), 8423. https://doi.org/10.3390/ijms22168423